Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Heart Failure I: Introduction

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...

Heart Failure II: Pathophysiology

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

Hyperthyroidism II: Pathophysiology

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...

Pathophysiology of Heart Failure

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...

Hypothyroidism II: Pathophysiology

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...

Graves Disease II: Pathophysiology

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Cardiovascular risk after total thyroidectomy in patients with differentiated thyroid carcinoma undergoing levothyroxine replacement monotherapy.

Frontiers in endocrinology·2025

Same author

EndoBridge 2024: pearls and highlights.

Hormones (Athens, Greece)·2025

Same author

Atrial Fibrillation and Stroke: Updated Evidence on a Screening Program According to Serum TSH.

The Journal of clinical endocrinology and metabolism·2024

Same author

TSH Suppression in Differentiated Thyroid Cancer Patients. Still More Questions than Answers after 30 Years.

Thyroid : official journal of the American Thyroid Association·2024

Same author

Subclinical Hypothyroidism in Patients with Obesity and Metabolic Syndrome: A Narrative Review.

Nutrients·2024

Same author

Preliminary Results of a Double-Blind Randomized Controlled Trial Evaluating the Cardiometabolic Effects of Levothyroxine and Liothyronine Compared to Levothyroxine with Placebo in Athyreotic Low-Risk Thyroid Cancer Patients.

Thyroid : official journal of the American Thyroid Association·2023

Search research articles

Related Experiment Video

Updated: May 18, 2026

Implantation of an Isoproterenol Mini-Pump to Induce Heart Failure in Mice

Implantation of an Isoproterenol Mini-Pump to Induce Heart Failure in Mice

Published on: October 3, 2019

Mechanisms in endocrinology: Heart failure and thyroid dysfunction.

Bernadette Biondi¹

¹Department of Clinical and Molecular Endocrinology and Oncology, University of Naples Federico II, Italy. bebiondi@unina.it

European Journal of Endocrinology

|September 8, 2012

Summary

Thyroid disease, both overt and subclinical, increases heart failure (HF) risk. Promptly treating thyroid dysfunction is crucial for improving HF prognosis and patient outcomes.

Related Experiment Videos

Last Updated: May 18, 2026

Implantation of an Isoproterenol Mini-Pump to Induce Heart Failure in Mice

Implantation of an Isoproterenol Mini-Pump to Induce Heart Failure in Mice

Published on: October 3, 2019

Area of Science:

Endocrinology
Cardiology
Internal Medicine

Background:

Heart failure (HF) is a significant cause of illness and death in Europe and the US.
Thyroid disease is increasingly recognized as a contributing factor to cardiovascular morbidity.

Purpose of the Study:

To review prospective studies on the risk of HF in patients with overt and subclinical thyroid disease.
To discuss the underlying mechanisms of thyroid dysfunction's impact on heart function.

Main Methods:

Systematic literature search for studies on thyroid disease and HF.
Inclusion of reports in English, focusing on specific search terms related to thyroid function and cardiac parameters.
Analysis of prospective studies evaluating HF risk.

Main Results:

Untreated overt thyroid dysfunction significantly elevates HF risk.
Persistent subclinical thyroid dysfunction (TSH <0.1 or >10 mU/l) is linked to HF development.
Thyroid status directly impacts cardiac function, including heart rate, systolic, and diastolic function.

Conclusions:

Early identification and management of cardiac symptoms in thyroid dysfunction are essential.
Effective treatment of thyroid dysfunction can improve the prognosis of heart failure.
Addressing thyroid health is a critical component of comprehensive cardiovascular care.